I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Mitsufuji, Hisashi
58
results:
Search for persons
X
Format
Online (58)
Mediatypes
Articles (Online) (33)
Bookchapter (Online) (1)
OpenAccess-fulltext (24)
Sorted by: Relevance
Sorted by: Year
?
1
The Glasgow Prognostic Score Predicts Survival in Patients ..:
Akazawa, Yuki
;
Igawa, Satoshi
;
Yamada, Kaori
...
Oncology. 101 (2023) 11 - p. 685-694 , 2023
Link:
https://doi.org/10.1159/..
?
2
The Glasgow Prognostic Score Predicts Survival Outcomes in ..:
Igawa, Satoshi
;
Yamamoto, Hiroki
;
Yamada, Kaori
...
Oncology. 101 (2023) 11 - p. 695-704 , 2023
Link:
https://doi.org/10.1159/..
?
3
Real-world evaluation of second line chemotherapy for patie..:
Igawa, Satoshi
;
Yokoba, Masanori
;
Takakura, Akira
...
Investigational New Drugs. 40 (2021) 1 - p. 182-189 , 2021
Link:
https://doi.org/10.1007/..
?
4
A Prospective Observational Study of Osimertinib for Chemo-..:
Igawa, Satoshi
;
Kasajima, Masashi
;
Ono, Taihei
...
Cancer Management and Research. 13 (2021) - p. 8695-8705 , 2021
Link:
https://doi.org/10.2147/..
?
5
Impact of neutrophil-to-lymphocyte ratio in patients with E..:
Ono, Taihei
;
Igawa, Satoshi
;
Kurahayashi, Shintaro
...
Investigational New Drugs. 38 (2020) 3 - p. 885-893 , 2020
Link:
https://doi.org/10.1007/..
?
6
Current status and progress of concurrent chemoradiotherapy..:
Fukui, Tomoya
;
Hosotani, Shinji
;
Soda, Itaru
...
Thoracic Cancer. 11 (2020) 4 - p. 1005-1014 , 2020
Link:
https://doi.org/10.1111/..
?
7
Real-world assessment of afatinib for patients with EGFR-po..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
Investigational New Drugs. 38 (2020) 6 - p. 1906-1914 , 2020
Link:
https://doi.org/10.1007/..
?
8
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
Cancer Management and Research. 12 (2020) - p. 4911-4921 , 2020
Link:
https://doi.org/10.2147/..
?
9
Questionnaire survey on patient awareness of invasive rebio..:
Fukui, Tomoya
;
Ishihara, Mikiko
;
Kasajima, Masashi
...
Thoracic Cancer. 10 (2019) 3 - p. 501-507 , 2019
Link:
https://doi.org/10.1111/..
?
10
Prognostic differences between oligometastatic and polymeta..:
Shirasawa, Masayuki
;
Fukui, Tomoya
;
Kusuhara, Seiichiro
...
PLOS ONE. 14 (2019) 4 - p. e0214599 , 2019
Link:
https://doi.org/10.1371/..
?
11
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocy..:
Fukui, Tomoya
;
Okuma, Yuriko
;
Nakahara, Yoshiro
...
Clinical Lung Cancer. 20 (2019) 3 - p. 208-214.e2 , 2019
Link:
https://doi.org/10.1016/..
?
12
Amrubicin monotherapy for elderly patients with relapsed ex..:
Sone, Hideyuki
;
Igawa, Satoshi
;
Kasajima, Masashi
...
Thoracic Cancer. 9 (2018) 10 - p. 1279-1284 , 2018
Link:
https://doi.org/10.1111/..
?
13
Real-world evaluation of carboplatin plus a weekly dose of ..:
Igawa, Satoshi
;
Nishinarita, Noriko
;
Takakura, Akira
...
Cancer Management and Research. 10 (2018) - p. 7013-7019 , 2018
Link:
https://doi.org/10.2147/..
?
14
Prognostic significance of the 8th edition of the TNM class..:
Shirasawa, Masayuki
;
Fukui, Tomoya
;
Kusuhara, Seiichiro
...
Cancer Management and Research. 10 (2018) - p. 6039-6047 , 2018
Link:
https://doi.org/10.2147/..
?
15
Intracranial Response to Nivolumab in a Patient with PD-L1-..:
Nakahara, Yoshiro
;
Fukui, Tomoya
;
Shirasawa, Masayuki
...
Internal Medicine. 57 (2018) 21 - p. 3149-3152 , 2018
Link:
https://doi.org/10.2169/..
1-15